We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Transgene SA | EU:TNG | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.005 | -0.71% | 0.695 | 0.695 | 0.70 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.705 | 0.695 | 0.70 | 10,900 | 13:00:00 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/11/2024 | 16:45 | UKREG | Transgene and NEC Present New Data Confirming Clinical Proof of Principle.. |
| 07/11/2024 | 16:45 | UKREG | Transgene et NEC présentent de nouvelles données confirmant la preuve de.. |
| 07/11/2024 | 16:45 | UKREG | Transgene Reports Business, Pipeline and Financial Update for Q3 2024 |
| 07/11/2024 | 16:45 | UKREG | Transgene fait le point sur ses activités, son portefeuille et sa situation.. |
| 05/11/2024 | 06:30 | UKREG | Transgene et ProBioGen collaborent pour faire progresser le développement.. |
| 05/11/2024 | 06:30 | UKREG | Transgene and ProBioGen Join Forces to Advance Individualized Cancer.. |
| 14/10/2024 | 05:30 | UKREG | Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique.. |
| 14/10/2024 | 05:30 | UKREG | Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine.. |
| 07/10/2024 | 06:00 | UKREG | Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024 |
| 07/10/2024 | 06:00 | UKREG | Transgene présentera un poster sur les données actualisées de TG4050 au.. |
1 Year Transgene Chart |
Intraday Transgene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
